ArticleBioorganic & medicinal chemistry letters2018

Utilizing a structure-based docking approach to develop potent G protein-coupled receptor kinase (GRK) 2 and 5 inhibitors.

Helen V Waldschmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.